Affordable and innovative healthcare products for all, has been our primary objective. We have an advanced research facility for development of Active Pharmaceutical Ingredients at our Durgapur unit with a dedicated team of experts and specialists working towards cutting-edge synthetic and analytical development.
We manufacture advanced APIs like QIC (Quinidochlor), for captive consumption for our product Enteroquinol Tablet, with an installed capacity of over 129999.6 kilograms per annum. We also develop Colloidal Iron, for captive consumption for our products Tonoferon, Tonoferon Drops and Tonoferon Paediatric Syrup, with an installed capacity of over 219.72 kiloliters per annum.
Our research and development of APIs is based on advanced technologies, refined expertise, innovative mindset and utmost care
Affordable and innovative healthcare products for all, has been our primary objective. We have an advanced research facility for development of Active Pharmaceutical Ingredients at our Durgapur unit with a dedicated team of experts and specialists working towards cutting-edge synthetic and analytical development.
We manufacture advanced APIs like QIC (Quinidochlor), for captive consumption for our product Enteroquinol Tablet, with an installed capacity of over 129999.6 kilograms per annum. We also develop Colloidal Iron, for captive consumption for our products Tonoferon, Tonoferon Drops and Tonoferon Paediatric Syrup, with an installed capacity of over 219.72 kiloliters per annum.
Our research and development of APIs is based on advanced technologies, refined expertise, innovative mindset and utmost care towards quality, safety and effectiveness of drugs on consumers. And with state-of-the-art infrastructure and high-precision operations, we deliver cost-effective and superior quality APIs, consistently.
towards quality, safety and effectiveness of drugs on consumers. And with state-of-the-art infrastructure and high-precision operations, we deliver cost-effective and superior quality APIs, consistently.
© Copyright 2019 East India Pharmaceutical Works Limited
GSTIN: 19AAACE5779P2ZR & 19AAACE5779P1ZS | CIN: U24231WB1936PLC008598
GSTIN: 19AAACE5779P2ZR & 19AAACE5779P1ZS
CIN: U24231WB1936PLC008598